Creegan & Nassoura Financial Group’s Sanofi SNY Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,200	Closed	-$472K	–	75
2022 Q1	$472K	Sell	9,200 -3,975	-30%	-$205K	0.35%	65
2021 Q4	$660K	Sell	13,175 -575	-4%	-$28.4K	0.5%	60
2021 Q3	$663K	Sell	13,750 -175	-1%	-$8.9K	0.57%	57
2021 Q2	$733K	Sell	13,925 -15,325	-52%	-$800K	0.63%	53
2021 Q1	$1.45M	Sell	29,250 -1,950	-6%	-$93.7K	1.29%	35
2020 Q4	$1.52M	Sell	31,200 -100	-0.3%	-$4.93K	1.46%	32
2020 Q3	$1.57M	Hold	31,300	–	–	1.69%	26
2020 Q2	$1.6M	Hold	31,300	–	–	1.8%	25
2020 Q1	$1.37M	Hold	31,300	–	–	1.79%	25
2019 Q4	$1.57M	Buy	+31,300	New	+$1.47M	1.58%	27
2016 Q3	$1.61M	Sell	42,150 -300	-0.7%	-$12K	1.88%	23
2016 Q2	$1.78M	Sell	42,450 -1,500	-3%	-$61.5K	2.1%	18
2016 Q1	$1.76M	Sell	43,950 -600	-1%	-$24.1K	2.09%	17
2015 Q4	$1.9M	Sell	44,550 -670	-1%	-$30.8K	2.16%	15
2015 Q3	$2.15M	Sell	45,220 -250	-0.5%	-$12.7K	2.45%	8
2015 Q2	$2.25M	Sell	45,470 -125	-0.3%	-$6.33K	2.34%	12
2015 Q1	$2.25M	Buy	+45,595	New	+$2.18M	2.32%	13

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Creegan & Nassoura Financial Group's SNY Position: Q2 2022 in Review

Creegan & Nassoura Financial Group sold out of Sanofi (SNY) in Q2 2022, closing a stake of 9,200 shares — an estimated $472K sold.

Creegan & Nassoura Financial Group first reported a position in SNY in Q1 2015 and held it in 17 quarters. The position peaked at $2.25M in Q1 2015. 655 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

Creegan & Nassoura Financial Group reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
Creegan & Nassoura Financial Group sold 9,200 Sanofi shares in Q2 2022, an estimated $472K.
Creegan & Nassoura Financial Group first reported a position in Sanofi in Q1 2015 and held it in 17 quarters.
Creegan & Nassoura Financial Group's Sanofi position peaked at $2.25M in Q1 2015.
655 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Creegan & Nassoura Financial Group's 13F filing for Q2 2022, filed 15 Aug 2022.